Stem-cell firms surge as Obama fuels funding hopes

BANGALORE (Reuters) - Shares of companies developing therapies based on stem cells surged on Monday, after confirmation over the weekend that U.S. president-elect Barack Obama plans to reverse an existing executive order against federal funding of embryonic stem-cell research.

Read the whole article on Reuters:Science

More from Reuters:Science